Powder: -20°C for 3 years | In solvent: -80°C for 2 years
Enfenamic acid is a Platelet aggregation inhibitor and with antirheumatic.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 133.00 | |
2 mg | In stock | $ 198.00 | |
5 mg | In stock | $ 297.00 | |
10 mg | In stock | $ 453.00 | |
25 mg | In stock | $ 747.00 | |
50 mg | In stock | $ 1,050.00 | |
100 mg | In stock | $ 1,420.00 |
Description | Enfenamic acid is a platelet aggregation inhibitor and with antirheumatic. |
In vivo | Dose-matched comparison between zinc-salt of enfenamic acid and the parent compound was carried out in experimentally wounded male albino rats bearing either sutured incision, dead-space or excision wounds. Result showed that enfenamic-acid significantly decreased breaking-strength of incision wounds and this effects was totally reversed by zinc present in enfenamic acid-zinc salt. Both the parent compound and the salt had significant granulation suppressant effect in dead-space wounds. In excision wounds epithelization was enhanced by enfenamic acid only. The wound contraction was not affected by either test compound. |
Molecular Weight | 241.2851 |
Formula | C15H15NO2 |
CAS No. | 23049-93-6 |
Powder: -20°C for 3 years | In solvent: -80°C for 2 years
DMSO: 5 mM
( < 1 mg/ml refers to the product slightly soluble or insoluble )
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
ENFENAMIC ACID 23049-93-6 Others Platelet aggregation nonsteroidal wound healing Inhibitor suppress RH-8 RH8 inhibit RH 8 anti-inflammatory Tromaril inhibitor